Johnson & Johnson (JNJ) will, over the next four months, phase out four surgical mesh products used to treat pelvic collapse in women, the Associated Press reported Tuesday.

The Food and Drug Administration has ordered new studies of the products as it has received hundreds of reports of complications related to the implants, according to earlier reports.

Pelvic-mesh products products, also made by companies including Boston Scientific Corp. (BSX) and C.R. Bard Inc. (BCR), are also at the center of lawsuits in New Jersey and West Virginia.

Full story at http://hosted.ap.org/dynamic/stories/U/US_JJ_PELVIC_IMPLANT?SITE=AP&SECTION=HOME&TEMPLATE=DEFAULT

Write to nymonitoring@dowjones.com

Bard C R (NYSE:BCR)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Bard C R Charts.
Bard C R (NYSE:BCR)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Bard C R Charts.